cefdinir
- Product NDC
- 68071-2564
- 11-digit product format
- 680712564
- Labeler code
- 68071
- Product ID
- 68071-2564_cff998a8-4b3e-3b25-e053-2a95a90a5cd6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cefdinir
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA210534
- Marketing category
- ANDA
- Marketing start
- 2021-02-20
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2564-6 | cefdinir | 60 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 60 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2564 | CEFDINIR POWDER, FOR SUSPENSION [NUCARE PHARMACEUTICALS,INC.] | 2 | Legacy NDC, 1 package rows | 20230718_cff998a8-4b3d-3b25-e053-2a95a90a5cd6.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2564-6 | 68071256406 | 60 mL in 1 BOTTLE (68071-2564-6) | 60 ml | 2021-11-04 | 0000-00-00 | No | No | Current |